Burkina Faso vs Chad: HIV-positive TB patients on ART (antiretroviral therapy)
Burkina Faso
100.0%
in 2024
Chad
100.0%
in 2024
Burkina Faso rank
1st
Chad rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Burkina Faso
- Chad
How they compare
Burkina Faso currently reports 100.0% against 100.0% in Chad, a difference of 0.0%.
The two have swapped places 1 time across 14 shared years of data; in 2010 it was Burkina Faso ahead.
Burkina Faso ranks 1st and Chad ranks 1st of 144 countries.
Across the 2 decades both report, Burkina Faso averaged higher in 1 and Chad in 1.
Head to head by decade
| Decade | Burkina Faso | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.2% | 61.1% | 17.1% | Burkina Faso |
| 2020s | 94.2% | 99.4% | 5.2% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Burkina Faso or Chad?
- Burkina Faso, at 100.0% against 100.0% in Chad as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Burkina Faso and Chad?
- 0.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Chad?
- 14 years are reported by both, from 2010 to 2024.
- How do Burkina Faso and Chad rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Burkina Faso ranks 1st and Chad ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.